137 related articles for article (PubMed ID: 33861874)
1. Allergic contact dermatitis probably due to brimonidine tartrate in eyedrops.
Napolitano M; Potestio L; Castagliola C; Fabbrocini G; Patruno C
Contact Dermatitis; 2021 Sep; 85(3):382-384. PubMed ID: 33861874
[No Abstract] [Full Text] [Related]
2. [Allergic contact dermatitis to Mirvaso
Schmutz JL
Ann Dermatol Venereol; 2017 Jan; 144(1):86-87. PubMed ID: 27692690
[No Abstract] [Full Text] [Related]
3. Case Report: Allergic Contact Dermatitis to Topical Brimonidine Demonstrated With Patch Testing: Insights on Evaluation of Brimonidine Sensitization.
Ringuet J; Houle MC
J Cutan Med Surg; 2018; 22(6):636-638. PubMed ID: 30016883
[No Abstract] [Full Text] [Related]
4. Dermatological side effects of brimonidine: a report of three cases.
Sodhi PK; Verma L; Ratan J
J Dermatol; 2003 Sep; 30(9):697-700. PubMed ID: 14578562
[TBL] [Abstract][Full Text] [Related]
5. Allergic contact dermatitis due to dorzolamide eyedrops.
Shimada M; Higaki Y; Kawashima M
Contact Dermatitis; 2001 Jul; 45(1):52. PubMed ID: 11422277
[No Abstract] [Full Text] [Related]
6. Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up.
Yeh PH; Cheng YC; Shie SS; Lee YS; Shen SC; Chen HS; Wu WC; Su WW
Medicine (Baltimore); 2021 Jul; 100(29):e26724. PubMed ID: 34398046
[TBL] [Abstract][Full Text] [Related]
7. Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
Manni G; Centofanti M; Sacchetti M; Oddone F; Bonini S; Parravano M; Bucci MG
J Glaucoma; 2004 Apr; 13(2):163-7. PubMed ID: 15097264
[TBL] [Abstract][Full Text] [Related]
8. Periocular allergic contact dermatitis caused by brinzolamide.
Navarro-Triviño FJ; Ruiz-Villaverde R
Contact Dermatitis; 2021 Apr; 84(4):274-276. PubMed ID: 33094487
[No Abstract] [Full Text] [Related]
9. Contact allergy to dorzolamide eyedrops.
Aalto-Korte K
Contact Dermatitis; 1998 Oct; 39(4):206. PubMed ID: 9817238
[No Abstract] [Full Text] [Related]
10. Allergic contact dermatitis to topical brimonidine.
Rajagopalan A; Rajagopalan B
Australas J Dermatol; 2015 Aug; 56(3):235. PubMed ID: 26201375
[No Abstract] [Full Text] [Related]
11. A review of neuropsychiatric adverse events from topical ophthalmic brimonidine.
Cimolai N
Hum Exp Toxicol; 2020 Oct; 39(10):1279-1290. PubMed ID: 32347114
[TBL] [Abstract][Full Text] [Related]
12. Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort R; Paula JS; Lopes Silva MJ; Della Paolera M; Kim T; Chen MY; Goodkin ML
Clin Ther; 2020 Feb; 42(2):263-275. PubMed ID: 32089329
[TBL] [Abstract][Full Text] [Related]
13. Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
Bangsgaard N; Fischer LA; Zachariae C
Contact Dermatitis; 2016 Jun; 74(6):378-9. PubMed ID: 27133629
[No Abstract] [Full Text] [Related]
14. The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
Jin SW; Lee SM
J Ocul Pharmacol Ther; 2018 Apr; 34(3):274-279. PubMed ID: 29297751
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.
Cookson H; McFadden J; White J; White IR
Contact Dermatitis; 2015 Dec; 73(6):366-7. PubMed ID: 26768997
[No Abstract] [Full Text] [Related]
16. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Jun; 34(6):1438-1448. PubMed ID: 28508306
[TBL] [Abstract][Full Text] [Related]
17. Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use.
Maruyama Y; Ikeda Y; Yokoi N; Mori K; Kato H; Ueno M; Kinoshita S; Sotozono C
Cornea; 2017 Dec; 36(12):1567-1569. PubMed ID: 28938378
[TBL] [Abstract][Full Text] [Related]
18. A case of contact dermatitis caused by timolol in anti-glaucoma eyedrops.
Otero-Rivas MM; Ruiz-González I; Valladares-Narganes LM; Delgado-Vicente S; Rodríguez-Prieto MÁ
Contact Dermatitis; 2015 Oct; 73(4):256-7. PubMed ID: 26094704
[No Abstract] [Full Text] [Related]
19. Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy.
Lee JS; Kim CY
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):911-919. PubMed ID: 35951740
[TBL] [Abstract][Full Text] [Related]
20. Systemic allergic contact dermatitis due to phenylephrine in eyedrops, with a long-lasting allergic patch test reaction.
Tamagawa-Mineoka R; Katoh N; Yoneda K; Cho Y; Kishimoto S
Eur J Dermatol; 2010; 20(1):125-6. PubMed ID: 19822484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
